TLSA/ 09/03/2026 · 6:52 AM BTIG Starts Coverage on Tiziana With Buy Rating as Key MS Trial Nears Nasal foralumab aims to cut brain inflammation in SPMS and MSA ahead of October INFORM-MS data.
